Core Viewpoint - Signify proposes changes to its Supervisory Board, including new appointments and re-appointments, to enhance its governance and strategic direction [1][9]. Group 1: Proposed Appointments - The Supervisory Board proposes to appoint Barbara Holzapfel and Jeroen Hoencamp as new members, who will attend meetings as observers starting March 1, 2026, until their official appointment [2][11]. - Barbara Holzapfel has extensive experience in technology and marketing, having held significant roles at companies like SAP and Microsoft, and currently serves on the board of Blackline Safety Corp [3][4]. - Jeroen Hoencamp has a strong background in telecommunications, having served as CEO of VodafoneZiggo and currently advising GIC, with a focus on business and IT transformations [5][6]. Group 2: Re-appointments and Changes - The Supervisory Board proposes the re-appointment of Bram Schot, who has been a member since May 2022, contributing to the company's long-term objectives [7]. - Jeroen Drost will assume the role of Chair of the Supervisory Board effective March 1, 2026, succeeding Gerard van de Aast, who will remain until the end of his term in 2027 [8]. - Rita Lane will step down from the Supervisory Board after a decade of service, having been a member since the company's IPO in 2016 [10][11]. Group 3: Company Overview - Signify is the world leader in lighting, with sales of EUR 5.8 billion in 2025 and a workforce of approximately 27,000 employees, operating in over 70 markets [12]. - The company is recognized for its sustainability efforts, being included in the Dow Jones Sustainability World Index and earning a CDP 'A' score for climate performance [12].

Core Insights - Vaisala Corporation has published its Annual Report for 2025, which includes the Board of Directors' Report, Consolidated and Parent Company Financial Statements, Auditor's Report, and Remuneration Report [1] - The Sustainability statement in the report adheres to the European Sustainability Reporting Standards (ESRS) and the Finnish Accounting Act [1] Group 1 - The Annual Report is accessible on the company's website and includes separate documents for the Corporate Governance Statement and Remuneration Report [2] - Vaisala's financial statements are published in the European Single Electronic Format (ESEF), with primary financial statements labeled with XBRL tags [3] - An independent auditor's report by PricewaterhouseCoopers Oy has been provided for Vaisala's ESEF financial statements [3] Group 2 - Vaisala is recognized as a global leader in measurement instruments and intelligence for climate action, focusing on resource efficiency and energy transition [4] - The company has over 90 years of innovation and employs approximately 2,500 experts dedicated to environmental measures [4] - Vaisala's series A shares are listed on the Nasdaq Helsinki stock exchange [4]

Core Insights - Technip Energies, in collaboration with JGC and Samsung Heavy Industries, has secured a significant contract from Mozambique Rovuma Venture (MRV) to advance the Coral Norte Floating Liquefied Natural Gas (FLNG) project, marking Mozambique's second floating LNG facility [1][12][14] Group 1: Project Details - The contract builds upon a previously announced agreement for early works, confirming the ongoing progress of Technip Energies' involvement in the Coral Norte FLNG project [2] - Coral Norte is designed as an enhanced replica of the successful Coral Sul project, utilizing the same feed gas composition and field location, which aims to improve project execution efficiency and LNG capacity [3] - The hull launch for the Coral Norte project took place on January 16, 2026, in Geoje, South Korea, indicating rapid advancement through early works and the adoption of a replica concept [2] Group 2: Company Expertise and Partnerships - Loïc Chapuis, President of Project Delivery & Services at Technip Energies, emphasized the project as a testament to the company's engineering and project delivery expertise, highlighting the successful replication of proven solutions [4] - The contract strengthens Technip Energies' long-standing partnership with Eni and its Area 4 partners, reinforcing the company's leadership in delivering innovative LNG solutions [4] Group 3: Company Overview - Technip Energies is recognized as a global technology and engineering powerhouse, with leadership in sectors such as LNG, hydrogen, and sustainable chemistry, contributing to critical markets including energy and decarbonization [5] - The company reported revenues of €6.9 billion in 2024 and operates with over 17,000 employees across 34 countries, committed to sustainability and innovation [6]

Core Insights - Nicox SA presented positive Phase 3 data for NCX 470 at the 2026 American Glaucoma Society Annual Meeting, highlighting its potential as a new treatment for glaucoma [1][3] - NCX 470 demonstrated a best-in-class intraocular pressure (IOP) lowering efficacy of up to 10mmHg from baseline, meeting the efficacy requirements for New Drug Applications in the U.S. and China [2][3] Company Overview - Nicox SA is an international ophthalmology company focused on developing innovative solutions for vision maintenance and ocular health [8] - The lead product, NCX 470, is a nitric oxide-donating bimatoprost eye drop aimed at lowering IOP in patients with open-angle glaucoma or ocular hypertension [8] Clinical Trial Results - The DENALI Trial showed that NCX 470 0.1% was non-inferior to latanoprost 0.005% at all time points, with NCX 470 achieving statistically superior IOP reductions at 3 out of 6 evaluated time points [4][7] - NCX 470 was found to be safe and well tolerated, with low discontinuation rates and no serious adverse events reported [5][7] Mechanism of Action - NCX 470 operates through a dual mechanism of action, enhancing both trabecular meshwork and uveoscleral outflow to lower IOP [3][6] - Preclinical data suggest potential benefits in retinal protection, further differentiating NCX 470 from existing treatments [3] Market Potential - Approximately 40% of glaucoma patients do not reach their target IOP with current monotherapies, indicating a significant need for new treatment options [3] - Nicox's strategic partnerships for NCX 470 include licensing agreements with Ocumension Therapeutics and Kowa for various markets [8]

Core Insights - The company achieved strong free cash flow of €350 million in 2025 despite a challenging market environment, with a focus on strategic and sustainability commitments [4][6] - Underlying net sales for 2025 were €4.3 billion, reflecting a 6.5% organic decline compared to 2024, while underlying EBITDA was €881 million, down 13.4% organically [6][14] - The company is committed to its "Essential chemistry" strategy, emphasizing cost savings and disciplined capital allocation to navigate market softness and geopolitical uncertainties [5][8] Financial Performance - Q4 2025 net sales were €995 million, a 12.3% decrease year-on-year, while FY 2025 net sales totaled €4,262 million, down 9.0% [2] - EBITDA for Q4 2025 was €169 million, a 33.9% decline year-on-year, with an EBITDA margin of 17.0% [2] - The underlying net profit from continuing operations was €306 million in 2025, compared to €445 million in 2024 [6] Cost Management and Strategic Initiatives - The company generated over €200 million in cost savings over the past two years, focusing on digitalization and simplification [5] - Structural cost savings initiatives contributed €101 million in 2025, with cumulative savings reaching €211 million [6] - Transformation expenses negatively impacted EBITDA by €27 million and free cash flow by €71 million in 2025 [6] Dividend and Future Outlook - A total proposed gross dividend of €2.43 per share is subject to shareholder approval, with a stable-to-increasing dividend policy confirmed [11] - For 2026, the company expects underlying EBITDA to be between €770 million and €850 million, with free cash flow projected to be at least €200 million [9][13] - The company anticipates continued geopolitical and macroeconomic challenges, impacting end-market demand and pricing pressure [9]

Core Points - The Annual General Meeting of Sika AG is scheduled for March 24, 2026, with all current Board members standing for re-election except Paul Schuler [2][6] - The Board proposes to increase the gross dividend by 2.8% to CHF 3.70 per share, up from CHF 3.60 the previous year [3][6] - The complete agenda for the meeting will be sent to shareholders on February 25, 2026, and published in the Swiss Official Gazette of Commerce [4] Company Profile - Sika is a leading specialty chemicals company focused on bonding, sealing, damping, reinforcing, and protection products for the construction and industrial sectors [5] - The company operates in 102 countries, with over 400 production facilities, and employs approximately 33,700 people [5] - In 2025, Sika reported annual sales of CHF 11.20 billion, highlighting its significant market presence [5]

Core Insights - FORVIA's 2025 results show ongoing margin improvement and deleveraging, supported by strong cash flow generation [2][3] - The company is focused on three strategic priorities: delivering performance, driving business transformation, and invigorating culture [2][3] Financial Performance - Reported sales for 2025 were €26.2 billion, or €27 billion at constant currency, remaining flat year-on-year [7] - Operating margin improved to 5.6% of sales, up 40 basis points compared to 2024 [7] - Net cash flow increased by 47% to €962 million [7] - Net debt decreased by €0.6 billion to €6.0 billion, with a net debt to adjusted EBITDA ratio of 1.7x, down from 2.0x at the end of 2024 [7][18] Strategic Initiatives - The planned divestiture of the Interiors Business Group is in advanced negotiations and is expected to reduce net debt by over €1 billion [4][36] - The company has undertaken significant non-cash exceptional charges in 2025, reflecting disciplined portfolio decisions aligned with its simplification and resilience objectives [5][24] Market Context - Global automotive production increased by 3.9% to 93 million light vehicles in 2025, with strong growth in China offsetting declines in Europe and North America [9] - The unfavorable geographic mix effect for FORVIA was approximately 2.5 percentage points due to regional shifts [9] Operational Highlights - Organic sales were broadly stable, with product sales up 1.5%, offset by lower tooling sales [12] - The company achieved €165 million in restructuring savings and €63 million in synergies from the FORVIA HELLA integration, reaching a target of €400 million by the end of 2025 [13] 2026 Outlook - FORVIA anticipates a challenging production environment in 2026, with global automotive production projected to decline slightly to 92.8 million light vehicles [37] - The company aims to continue rigorous cost control and cash management, expecting further benefits from the EU-FORWARD and SIMPLIFY programs [38]

Core Insights - JDE Peet's experienced strong financial performance in 2025, achieving significant top-line growth and operational profit despite challenges from green coffee inflation [2][5][8] Financial Performance - Total sales for 2025 reached EUR 9.9 billion, reflecting a 15.3% organic growth driven by a 19.5% price increase, while volume/mix decreased by 4.3% [12][14] - Organic adjusted EBIT increased by 1.2% to EUR 1.3 billion, with reported sales up 12.3% [7][14] - Free cash flow was EUR 1,130 million, and net leverage improved to 2.3x [7][17] - Underlying profit for the period rose by 64.1% to EUR 1,196 million, with underlying EPS increasing to EUR 2.46 [16][14] Strategic Initiatives - The company launched the "Reignite the Amazing" strategy, focusing on three key brands: Peet's, L'OR, and Jacobs, along with nine local icons, aimed at sustainable value creation [3][6] - Progress was made in simplifying the organization and advancing a EUR 500 million cost savings program [3][7] - New product launches included Dubai Chocolate and Peet's ready-to-drink Cold Brew Coffee, enhancing consumer engagement [4][19] Market Developments - The acquisition process with Keurig Dr Pepper (KDP) is on track, with a public cash offer of EUR 31.85 per share supported by JDE Peet's Board of Directors [9][10] - The company is committed to maintaining affordability while managing cost inflation, which totaled EUR 1.6 billion in 2025 [8][16]

Core Insights - FORVIA has launched its new strategic roadmap called IGNITE, aimed at enhancing the Group's profile, reducing complexity, and enabling financial flexibility through disciplined deleveraging, which is expected to foster accelerated growth and sustained net cash flow generation in the medium term [2][4][25] Strategic Roadmap - IGNITE is structured around two key phases: Focus & Strengthen (2025-2028) and Lead & Grow (post-2028) [5][9] - The roadmap emphasizes a new portfolio framework that includes a Growth cluster (Electronics and Seating) and a Value cluster (Clarion, Clean Mobility, Lifecycle Solutions, and Lighting) [6][10] Financial Projections - By 2028, FORVIA anticipates sales of €21-22 billion at constant exchange rates, with an operating margin of at least 7.0% and net cash flow around 3.5% of sales [5][20] - The leverage ratio is projected to improve to 1.2x by 2028, indicating a solid financial structure [20] Growth and Value Clusters - The Growth cluster is expected to achieve sales of €8.7-€9.1 billion by 2028, with an operating margin of at least 6.5% [12] - The Value cluster's sales are projected to adjust to €8.4-€8.8 billion by 2028, with an operating margin expanding to at least 7.0% [15] Operational Excellence - IGNITE aims to enhance operational excellence through improved capital allocation and a focus on best-in-class performance, supported by initiatives like EU-FORWARD and SIMPLIFY [4][16] - The Group's approach is underpinned by the FORVIA Excellence System, which emphasizes execution discipline and profitability across operations [16][17] Cultural and Organizational Changes - FORVIA is evolving its organizational structure to become simpler and faster, with a focus on regional divisions that enhance proximity to customers and operational accountability [18][19] - The Group is reinforcing its leadership culture, emphasizing accountability, empowerment, and collaboration to support faster decision-making [19]

Core Insights - Lerøy Seafood Group reported solid operations and good biological performance in Q4 2025, with an operational EBIT of NOK 758 million, driven by strong contributions from Farming and the Value-Added Processing, Sales and Distribution (VAP S&D) segment [1] Farming Segment - The farming segment achieved an operational EBIT of NOK 564 million in Q4 2025, slightly lower than the same period last year, but salmon and trout prices improved significantly towards the end of the quarter [2] - Biological performance in the farming segment was better than expected, and costs declined quarter-on-quarter, leading to a favorable biological situation entering 2026 [2] VAP S&D Segment - The VAP S&D segment delivered an operational EBIT of NOK 317 million in Q4 2025, marking a 15% increase compared to the same period last year [3] - The operational EBIT for the entire year 2025 reached NOK 1,290 million, surpassing the ambitious target of NOK 1.25 billion set in 2022 [3][4] Wild Catch Segment - The wild catch segment reported an operational EBIT of NOK -29 million in Q4 2025, a decline from NOK 6 million in the same quarter last year, due to lower catch volumes and high raw material prices impacting margins [5] Outlook for 2026 - For 2026, Lerøy expects a decrease in cost per produced kilo in farming compared to 2025, with a guided harvest volume in Norway remaining at 195,000 GWT and a total expected volume of 216,500 GWT including Scottish Sea Farms [6] - Continued good biological development is anticipated to result in high harvest volumes, which may initially lower salmon prices but is expected to be positive for long-term earnings [7]